Pharmacy- Page 186

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Bristol-Myers Squibb Announces Extension of U.S. Agreement for ABILIFY

The FINANCIAL -- Bristol-Myers Squibb Company (NYSE: BMY) on April 6 announced an agreement with Otsuka Pharmaceutical Co., Ltd. (hereafter, “Otsuka”) to extend the U.S. portion of the companies’ long-standing agreement for the development and commercialization of ABILIFY (aripiprazole) from the currently scheduled end

by The FINANCIAL

April 6, 2009

1 min read

Pharmacy

TRILIPIX in Combination With CRESTOR Shows Improvement on Key Lipids for Cholesterol Management

The FINANCIAL -- Data from a new study showed that Abbott's (NYSE: ABT) TRILIPIX (fenofibric acid) delayed-release capsules in combination with CRESTOR (rosuvastatin calcium) met all of the study's primary endpoints.

by The FINANCIAL

March 30, 2009

1 min read

Pharmacy

Takeda Expands its Own Sales and Marketing Operations in Europe

The FINANCIAL -- Takeda Pharmaceutical Company Limited (Osaka, Japan, “Takeda”) and its wholly-owned UK-based subsidiary for overseeing pan-European sales & marketing, Takeda Pharmaceutical Europe Limited (London, UK, “TPEU”) jointly announced on March 30 the start of its own sales and marketing operations in Spain,

by The FINANCIAL

March 30, 2009

1 min read

Pharmacy

Takeda Submitted a New Drug Application in Japan for Fixed Dose Combination of Blopress

The FINANCIAL -- Takeda Pharmaceutical Company Limited (“Takeda”) announced on March 30 that it submitted a New Drug Application to the Ministry of Health, Labour and Welfare for a fixed dose combination of Blopress (generic name: candesartan cilexetil) and amlodipine besylate for treatment of

by The FINANCIAL

March 30, 2009

1 min read

Pharmacy

CRESTOR reduced risk of blood clots in the veins

The FINANCIAL -- A new analysis from the JUPITER study shows that CRESTOR (rosuvastatin calcium) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p =0.007) compared to placebo among men and women with low to normal cholesterol levels and

by The FINANCIAL

March 30, 2009

1 min read

Pharmacy

Lilly Announces Inconclusive Phase II Study Results

The FINANCIAL -- Eli Lilly and Company (NYSE: LLY) announced on March 29 inconclusive Phase II clinical trial results from Study HBBI investigating LY2140023 monohydrate, also known as mGlu2/3, for the treatment of patients suffering from acute schizophrenia.

by The FINANCIAL

March 30, 2009

1 min read

Pharmacy

Daiichi Sankyo Files Patent Infringement Actions against 13 Generics Companies for CRAVIT TABLTETS

The FINANCIAL -- Daiichi Sankyo Company, Limited announced that it has brought patent infringement litigation against 13 generics companies for the substance patent (2008845) and usage patent (1659502) for Levofloxacin Hydrate (brand name: Cravit tablets and Cravit fine granules).

by The FINANCIAL

March 23, 2009

1 min read

Pharmacy

Marketing Authorisation for Prostap to Transfer Back to Takeda from Wyeth

The FINANCIAL -- Takeda Pharmaceutical Company Limited ("Takeda") on March 23 announced that it has signed an agreement with Wyeth for the product licence for Prostap (leuprorelin acetate), an LH-RH agonist, to transfer back to Takeda from Wyeth in the UK and Republic

by The FINANCIAL

March 23, 2009

1 min read

Pharmacy

Merck to buy Schering-Plough for $41.1 billion

The FINANCIAL -- Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) on March 9 announced that their Boards of Directors have unanimously approved a definitive merger agreement under which Merck and Schering-Plough will combine, under the name Merck, in a stock

by The FINANCIAL

March 9, 2009

9 mins read

Pharmacy

Sanofi Aventis Names Jerome Contamine As Finance Chief

The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on March 9 that Jérôme Contamine is appointed Executive Vice President, Chief Financial Officer (CFO) of sanofi-aventis, effective March 16, 2009.

by The FINANCIAL

March 9, 2009

1 min read